IL-6–based mortality prediction model for COVID-19: Validation and update in multicenter and second wave cohorts

BACKGROUND: Coronavirus disease 2019 (COVID-19) is a highly variable condition. Validated tools to assist in the early detection of patients at high risk of mortality can help guide medical decisions. OBJECTIVE: We sought to validate externally, as well as in patients from the second pandemic wave i...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:J Allergy Clin Immunol
Autores principales: Utrero-Rico, Alberto, Ruiz-Hornillos, Javier, González-Cuadrado, Cecilia, Rita, Claudia Geraldine, Almoguera, Berta, Minguez, Pablo, Herrero-González, Antonio, Fernández-Ruiz, Mario, Carretero, Octavio, Taracido-Fernández, Juan Carlos, López-Rodriguez, Rosario, Corton, Marta, Aguado, José María, Villar, Luisa María, Ayuso-García, Carmen, Paz-Artal, Estela, Laguna-Goya, Rocio
Formato: Artigo
Lenguaje:Inglês
Publicado: American Academy of Allergy, Asthma & Immunology 2021
Materias:
Covid-19
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC7919507/
https://ncbi.nlm.nih.gov/pubmed/33662370
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jaci.2021.02.021
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares